Tapentadol in the treatment of osteoarthritis: pharmacological rationale and clinical evidence
Osteoarthritis (OA) is the most prevalent joint disease in older people worldwide. Pain owing to OA is considered one of the most frequent causes of chronic pain; however, current pharmacological approaches have some limitations in terms of efficacy and safety. Of note, descending inhibitory pain pa...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529616/ https://www.ncbi.nlm.nih.gov/pubmed/31190964 http://dx.doi.org/10.2147/JPR.S190161 |